Novel CAR T cell therapy obe-cel demonstrates high response rates in adult patients with advanced B-cell ALL
Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel ...
The American Journal of Managed Care1d
Venetoclax May Be an Option for Children With R/R AML, MDS
The single-center report showed the therapy had a favorable safety profile and manageable side effects in children with ...
Hanford Sentinel1d
Understanding FeLV: What cat owners should know | Ask Dr. Kait
Feline Leukemia Virus is commonly referred to as FeLV. It is one of the most common infectious diseases in cats worldwide.
Cure Today2d
Focusing Research on T-Cell ALL to Further Treatment Options
An expert highlighted unmet needs in treating T-cell acute lymphoblastic leukemia and where research may focus in the future.